Company news: Vibrant

Share this article:

Contextual advertising firm Vibrant reported 58% growth in pharmaceutical-related revenue in the third quarter. The firm, which said it manages more than six billion hyperlinks, works with brands across prescription and OTC pharmaceuticals in major health categories such as rheumatoid arthritis, hypertension, diabetes, depression, stroke and cholesterol, according to a press release. Vibrant's contextual ad model is designed to allow pharmaceutical marketers to deliver targeted ads and information within relevant, condition-specific web content, working to connect users with brands and relevant content from a network of 4,500 publishers.

Share this article:

Email Newsletters

More in Business Briefs

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

UK generic use soared in 2013

Generics made up almost 75% of prescriptions in the United Kingdom last year.

GSK refutes consumer spin-off rumor

The company refutes a Financial Times rumor that one was happening soonish.